Skip to main content
Erschienen in: World Journal of Urology 3/2013

01.06.2013 | Original Article

Lower urinary tract symptoms in relation to region of birth in 95,393 men living in Australia: the 45 and Up Study

verfasst von: Isabel Latz, Marianne Weber, Rosemary Korda, David Smith, Mark Clements, Manish Patel, Terry Dwyer, Gabriella Tikellis, Emily Banks

Erschienen in: World Journal of Urology | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Lower urinary tract symptoms (LUTS) are very common among older men globally, but evidence regarding the relationship between LUTS and country of origin is limited. This study aimed to investigate the relationship between the prevalence of LUTS and region of birth in a large, ethnically diverse population of older men resident in New South Wales, Australia.

Methods

Data on LUTS, demographic and behavioural factors were collected by postal questionnaire from 2006 to 2009 and analysed for 95,393 men aged 45 and over from the 45 and Up Study, who had not had previous prostate surgery. Logistic regression was used to investigate the association between region of birth and moderate/severe LUTS, ascertained using a modified International Prostate Symptom Score, adjusting for age, income, education, alcohol consumption and smoking.

Results

Overall, 18,530 (19.4 %) men had moderate or severe LUTS. Compared to Australian-born men, prevalence of moderate/severe LUTS was significantly higher in men born in the Middle East & North Africa, Southeast Asia and North America regions (adjusted odds ratios (OR) = 1.43; 95 % CI = 1.23–1.66, OR = 1.25; 1.10–1.42, OR = 1.26; 1.05–1.52, respectively), whereas men from the UK & Ireland had significantly lower prevalence (OR = 0.85; 0.80–0.90). Patterns of association were generally similar for storage- and voiding-related types of LUTS. However, participants born in Sub-Saharan Africa showed a significantly elevated prevalence of moderate/severe voiding symptoms (1.22; 1.03–1.45) but not storage symptoms, compared to Australian-born respondents.

Conclusion

The prevalence of LUTS and of specific subtypes of LUTS varies according to region of birth.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Meigs JB, Mohr B, Barry MJ, Collins MM, McKinlay JB (2001) Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol 54(9):935–944PubMedCrossRef Meigs JB, Mohr B, Barry MJ, Collins MM, McKinlay JB (2001) Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol 54(9):935–944PubMedCrossRef
2.
Zurück zum Zitat Holden C, McLachlan R, Pitts M, Cumming RG, Wittert G, Agius P, Handelsman D, de Kretser D (2005) Men in Australia Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older Australian men. Lancet 366:218–224PubMedCrossRef Holden C, McLachlan R, Pitts M, Cumming RG, Wittert G, Agius P, Handelsman D, de Kretser D (2005) Men in Australia Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older Australian men. Lancet 366:218–224PubMedCrossRef
4.
Zurück zum Zitat Thorpe A, Neal D (2003) Benign prostatic hyperplasia. The Lancet 361(9366):1359–1367CrossRef Thorpe A, Neal D (2003) Benign prostatic hyperplasia. The Lancet 361(9366):1359–1367CrossRef
5.
Zurück zum Zitat Kang D, Andriole GL, Van De Vooren RC, Crawford D, Chia D, Urban DA, Reding D, Huang WY, Hayes RB (2004) Risk behaviours and benign prostatic hyperplasia. BJU Int 93(9):1241–1245PubMedCrossRef Kang D, Andriole GL, Van De Vooren RC, Crawford D, Chia D, Urban DA, Reding D, Huang WY, Hayes RB (2004) Risk behaviours and benign prostatic hyperplasia. BJU Int 93(9):1241–1245PubMedCrossRef
7.
Zurück zum Zitat Giovannucci E, Rimm EB, Chute CG, Kawachi I, Colditz GA, Stampfer MJ, Willett WC (1994) Obesity and benign prostatic hyperplasia. Am J Epidemiol 140(11):989–1002PubMed Giovannucci E, Rimm EB, Chute CG, Kawachi I, Colditz GA, Stampfer MJ, Willett WC (1994) Obesity and benign prostatic hyperplasia. Am J Epidemiol 140(11):989–1002PubMed
8.
Zurück zum Zitat Parsons JK, Kashefi C (2008) Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. Eur Urol 53(6):1228–1235PubMedCrossRef Parsons JK, Kashefi C (2008) Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. Eur Urol 53(6):1228–1235PubMedCrossRef
10.
Zurück zum Zitat Suzuki S, Platz EA, Kawachi I, Willett WC, Giovannucci E (2002) Intakes of energy and macronutrients and the risk of benign prostatic hyperplasia. Am J Clin Nutr 75(4):689–697PubMed Suzuki S, Platz EA, Kawachi I, Willett WC, Giovannucci E (2002) Intakes of energy and macronutrients and the risk of benign prostatic hyperplasia. Am J Clin Nutr 75(4):689–697PubMed
11.
Zurück zum Zitat Rohrmann S, Giovannucci E, Willett WC, Platz EA (2007) Fruit and vegetable consumption, intake of micronutrients, and benign prostatic hyperplasia in US men. Am J Clin Nutr 85(2):523–529PubMed Rohrmann S, Giovannucci E, Willett WC, Platz EA (2007) Fruit and vegetable consumption, intake of micronutrients, and benign prostatic hyperplasia in US men. Am J Clin Nutr 85(2):523–529PubMed
13.
Zurück zum Zitat Fitzgerald MP, Link CL, Litman HJ, Travison TG, McKinlay JB (2007) Beyond the lower urinary tract: the association of urologic and sexual symptoms with common illnesses. Eur Urol 52(2):407–415PubMedCrossRef Fitzgerald MP, Link CL, Litman HJ, Travison TG, McKinlay JB (2007) Beyond the lower urinary tract: the association of urologic and sexual symptoms with common illnesses. Eur Urol 52(2):407–415PubMedCrossRef
14.
Zurück zum Zitat Kristal AR, Schenk JM, Song Y, Arnold KB, Neuhouser ML, Goodman PJ, Lin DW, Stanczyk FZ, Thompson IM (2008) Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol 168(12):1416–1424. doi:10.1093/aje/kwn272 PubMedCrossRef Kristal AR, Schenk JM, Song Y, Arnold KB, Neuhouser ML, Goodman PJ, Lin DW, Stanczyk FZ, Thompson IM (2008) Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol 168(12):1416–1424. doi:10.​1093/​aje/​kwn272 PubMedCrossRef
15.
Zurück zum Zitat Neuhouser ML, Schenk J, Song YJ, Tangen CM, Goodman PJ, Pollak M, Penson DF, Thompson IM, Kristal AR (2008) Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial. Prostate 68(13):1477–1486. doi:10.1002/pros.20819 PubMedCrossRef Neuhouser ML, Schenk J, Song YJ, Tangen CM, Goodman PJ, Pollak M, Penson DF, Thompson IM, Kristal AR (2008) Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial. Prostate 68(13):1477–1486. doi:10.​1002/​pros.​20819 PubMedCrossRef
16.
Zurück zum Zitat Safarinejad MR (2008) Prevalence of benign prostatic hyperplasia in a population-based study in Iranian men 40 years old or older. Int Urol Nephrol 40(4):921–931PubMedCrossRef Safarinejad MR (2008) Prevalence of benign prostatic hyperplasia in a population-based study in Iranian men 40 years old or older. Int Urol Nephrol 40(4):921–931PubMedCrossRef
17.
Zurück zum Zitat Fritschi L, Tabrizi J, Leavy J, Ambrosini G, Timperio A (2007) Risk factors for surgically treated benign prostatic hyperplasia in Western Australia. Public Health 121(10):781–789PubMedCrossRef Fritschi L, Tabrizi J, Leavy J, Ambrosini G, Timperio A (2007) Risk factors for surgically treated benign prostatic hyperplasia in Western Australia. Public Health 121(10):781–789PubMedCrossRef
18.
Zurück zum Zitat Kristal AR, Arnold KB, Schenk JM, Neuhouser ML, Weiss N, Goodman P, Antvelink CM, Penson DF, Thompson IM (2007) Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. J Urol 177(4):1395–1400 quiz 1591PubMedCrossRef Kristal AR, Arnold KB, Schenk JM, Neuhouser ML, Weiss N, Goodman P, Antvelink CM, Penson DF, Thompson IM (2007) Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. J Urol 177(4):1395–1400 quiz 1591PubMedCrossRef
20.
Zurück zum Zitat Morrison AS (1992) Risk factors for surgery for prostatic hypertrophy. Am J Epidemiol 135(9):974–980PubMed Morrison AS (1992) Risk factors for surgery for prostatic hypertrophy. Am J Epidemiol 135(9):974–980PubMed
21.
Zurück zum Zitat Platz EA, Kawachi I, Rimm EB, Willett WC, Giovannucci E (2000) Race, ethnicity and benign prostatic hyperplasia in the health professionals follow-up study. J Urol 163(2):490–495PubMedCrossRef Platz EA, Kawachi I, Rimm EB, Willett WC, Giovannucci E (2000) Race, ethnicity and benign prostatic hyperplasia in the health professionals follow-up study. J Urol 163(2):490–495PubMedCrossRef
22.
Zurück zum Zitat Sladden MJ, Hughes AM, Hirst GH, Ward JE (2000) A community study of lower urinary tract symptoms in older men in Sydney, Australia. Aust N Z J Surg 70(5):322–328PubMedCrossRef Sladden MJ, Hughes AM, Hirst GH, Ward JE (2000) A community study of lower urinary tract symptoms in older men in Sydney, Australia. Aust N Z J Surg 70(5):322–328PubMedCrossRef
23.
Zurück zum Zitat Gupta A, Gupta S, Pavuk M, Roehrborn CG (2006) Anthropometric and metabolic factors and risk of benign prostatic hyperplasia: a prospective cohort study of Air Force veterans. Urology 68(6):1198–1205PubMedCrossRef Gupta A, Gupta S, Pavuk M, Roehrborn CG (2006) Anthropometric and metabolic factors and risk of benign prostatic hyperplasia: a prospective cohort study of Air Force veterans. Urology 68(6):1198–1205PubMedCrossRef
24.
Zurück zum Zitat Sidney S, Quesenberry CP Jr, Sadler MC, Guess HA, Lydick EG, Cattolica EV (1991) Incidence of surgically treated benign prostatic hypertrophy and of prostate cancer among blacks and whites in a prepaid health care plan. Am J Epidemiol 134(8):825–829PubMed Sidney S, Quesenberry CP Jr, Sadler MC, Guess HA, Lydick EG, Cattolica EV (1991) Incidence of surgically treated benign prostatic hypertrophy and of prostate cancer among blacks and whites in a prepaid health care plan. Am J Epidemiol 134(8):825–829PubMed
25.
Zurück zum Zitat Welch G, Kawachi I, Barry MJ, Giovannucci E, Colditz GA, Willett WC (1998) Distinction between symptoms of voiding and filling in benign prostatic hyperplasia: findings from the health professionals follow-up study. Urology 51(3):422–427PubMedCrossRef Welch G, Kawachi I, Barry MJ, Giovannucci E, Colditz GA, Willett WC (1998) Distinction between symptoms of voiding and filling in benign prostatic hyperplasia: findings from the health professionals follow-up study. Urology 51(3):422–427PubMedCrossRef
26.
27.
Zurück zum Zitat Barry MJ, Fowler FJ Jr, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT (1992) The American Urological Association symptom index for benign prostatic hyperplasia, the measurement committee of the American Urological Association. J Urol 148(5):1549–1557PubMed Barry MJ, Fowler FJ Jr, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT (1992) The American Urological Association symptom index for benign prostatic hyperplasia, the measurement committee of the American Urological Association. J Urol 148(5):1549–1557PubMed
28.
Zurück zum Zitat Harvard University, Institute for health metrics and evaluation at the University of Washington, Johns Hopkins University, University of Queensland, World Health Organization (2007) The global burden of diseases, injuries, and risk factors operations manual (draft) Harvard University, Institute for health metrics and evaluation at the University of Washington, Johns Hopkins University, University of Queensland, World Health Organization (2007) The global burden of diseases, injuries, and risk factors operations manual (draft)
29.
Zurück zum Zitat World Health Organization (1998) Obesity: preventing and managing the global epidemic. World Health Organization, Geneva World Health Organization (1998) Obesity: preventing and managing the global epidemic. World Health Organization, Geneva
30.
Zurück zum Zitat Dirks J, Remuzzi G, Horton S, Schieppati A, Hasan Rizvi SA (2006) Diseases of the kidney and the urinary system. In: Jamison DT, Breman JG, Measham AR et al (eds) Disease control priorities in developing countries, 2nd edn. Oxford University Press, New York Dirks J, Remuzzi G, Horton S, Schieppati A, Hasan Rizvi SA (2006) Diseases of the kidney and the urinary system. In: Jamison DT, Breman JG, Measham AR et al (eds) Disease control priorities in developing countries, 2nd edn. Oxford University Press, New York
32.
Zurück zum Zitat Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AMY, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF, Hyer MB (1993) Migration patterns and breast cancer risk in Asian–American women. J Natl Cancer Inst 85(22):1819–1827. doi:10.1093/jnci/85.22.1819 PubMedCrossRef Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AMY, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF, Hyer MB (1993) Migration patterns and breast cancer risk in Asian–American women. J Natl Cancer Inst 85(22):1819–1827. doi:10.​1093/​jnci/​85.​22.​1819 PubMedCrossRef
33.
Zurück zum Zitat Australian Bureau of Statistics (2006) Census of population and housing. Commonwealth of Australia Australian Bureau of Statistics (2006) Census of population and housing. Commonwealth of Australia
34.
Zurück zum Zitat Mealing NM, Banks E, Jorm LR, Steel DG, Clements MS, Rogers KD (2010) Investigation of relative risk estimates from studies of the same population with contrasting response rates and designs. BMC Med Res Methodol 10:26. doi:10.1186/1471-2288-10-26 PubMedCrossRef Mealing NM, Banks E, Jorm LR, Steel DG, Clements MS, Rogers KD (2010) Investigation of relative risk estimates from studies of the same population with contrasting response rates and designs. BMC Med Res Methodol 10:26. doi:10.​1186/​1471-2288-10-26 PubMedCrossRef
Metadaten
Titel
Lower urinary tract symptoms in relation to region of birth in 95,393 men living in Australia: the 45 and Up Study
verfasst von
Isabel Latz
Marianne Weber
Rosemary Korda
David Smith
Mark Clements
Manish Patel
Terry Dwyer
Gabriella Tikellis
Emily Banks
Publikationsdatum
01.06.2013
Verlag
Springer-Verlag
Erschienen in
World Journal of Urology / Ausgabe 3/2013
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-012-0937-7

Weitere Artikel der Ausgabe 3/2013

World Journal of Urology 3/2013 Zur Ausgabe

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.